{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:59:19Z","timestamp":1787029159505,"version":"build-2736575974"},"reference-count":47,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Medical management of epilepsy seeks to eliminate or to reduce the frequency of seizures, help patients maintain a normal lifestyle, and maintain psychosocial and occupational activities, while avoiding the negative side effects of long-term treatment. Current FDA approved drugs have been shown to have similar efficacy; however, they all share a commonality of having side effects that have the potential to significantly reduce a patient\u2019s quality of life. Cenobamate, a newly-FDA approved drug used to treat partial-onset seizures in adult patients, has demonstrated promise in that it works on two proposed mechanisms that are commonly associated with epilepsy. Cenobamate acts as a positive allosteric modulator of the GABAA ion channels and is effective in reducing repetitive neuronal firing by inhibition of voltage-gated sodium channels, although the complete mechanism of action is currently unknown. The efficacy of Cenobamate with its low toxicity and adverse drug reaction profile emphasizes the need to further evaluate antiepileptic therapies containing sulfamoylphenyl and\/or carbamate moieties in their chemical structure. Recent studies have found more patients to be seizure free during the maintenance period when compared to placebo. The most common side effects reported in with Cenobamate are somnolence, dizziness, headache, nausea, and fatigue. There are currently ongoing phase III studies looking to further evaluate the long-term benefits of Cenobamate and investigate adverse events.<\/jats:p>","DOI":"10.3390\/neurolint13020026","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T04:22:22Z","timestamp":1623212542000},"page":"252-265","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABAA Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications"],"prefix":"10.3390","volume":"13","author":[{"given":"Dustin R.","family":"Latimer","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine Louisiana State University Health Science Center Baton Rouge, Baton Rouge, LA 70808, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-6206","authenticated-orcid":false,"given":"Amber N.","family":"Edinoff","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Science Center Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel D.","family":"Ruff","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Health Sheveport, Sheveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3244-5878","authenticated-orcid":false,"given":"Kelsey C.","family":"Rooney","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Health Sheveport, Sheveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Penny","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Health Sheveport, Sheveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan B.","family":"Patel","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Health Sheveport, Sheveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Sabbenahalli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine Louisiana State University Health Science Center Baton Rouge, Baton Rouge, LA 70808, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7224-3322","authenticated-orcid":false,"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Thomas J. Long School of Pharmacy and Health Sciences, Department of Pharmacy Practice, University of the Pacific, Stockton, CA 94103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-3931","authenticated-orcid":false,"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[{"name":"College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA"},{"name":"Department of Anesthesiology, Creighton University School of Medicine, Omaha, NE 68124, USA"},{"name":"Valley Anesthesiology and Pain Consultants, Envision Physician Services, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-6085","authenticated-orcid":false,"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA"},{"name":"Southcoast Physicians Group Pain Medicine, Southcoast Health, Wareham, MA 02720, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-0187","authenticated-orcid":false,"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1460-9568.2006.04989.x","article-title":"Tonic GABAA receptor-mediated currents in human brain","volume":"24","author":"Scimemi","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1528-1157.1995.tb01005.x","article-title":"Incidence of Acute Symptomatic Seizures in Rochester, Minnesota, 1935\u20131984","volume":"36","author":"Annegers","year":"1995","journal-title":"Epilepsia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1553-2712.2001.tb00175.x","article-title":"Emergency department management of patients with seizures: A multicenter study","volume":"8","author":"Huff","year":"2001","journal-title":"Acad. Emerg. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0140-6736(90)92959-L","article-title":"MEDICAL SCIENCE. National General Practice Study of Epilepsy: Newly diagnosed epileptic seizures in a general population","volume":"336","author":"Sander","year":"1990","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.62.5_suppl_2.S24","article-title":"Special considerations in treating the elderly patient with epilepsy","volume":"62","author":"Ramsay","year":"2004","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1528-1157.1992.tb06222.x","article-title":"Seizure Disorders: The Changes With Age","volume":"33","author":"Hauser","year":"1992","journal-title":"Epilepsia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1528-1167.2011.03320.x","article-title":"Newly diagnosed epileptic seizures: Focus on an elderly population on the French island of R\u00e9union in the Southern Indian Ocean","volume":"52","author":"Tchalla","year":"2011","journal-title":"Epilepsia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3182477edc","article-title":"Incidence and prevalence of epilepsy among older US Medicare beneficiaries","volume":"78","author":"Faught","year":"2012","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1212\/WNL.0000000000003662","article-title":"Predictors of incident epilepsy in older adults: The Cardiovascular Health Study","volume":"88","author":"Choi","year":"2017","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.410270304","article-title":"A survey of epileptic disorders in Southwest France: Seizures in elderly patients","volume":"27","author":"Loiseau","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rho, J.M., Sankar, R., and Stafstrom, C.E. (2010). Epilepsy: Mechanisms, Models, and Translational Perspectives, CRC Press.","DOI":"10.1201\/EBK1420085594"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Patel, R., and Dickenson, A.H. (2016). Mechanisms of the gabapentinoids and \u03b12\u03b4-1 calcium channel subunit in neuropathic pain. Pharmacol. Res. Perspectives.","DOI":"10.1002\/prp2.205"},{"key":"ref_16","first-page":"1","article-title":"Seizures and epilepsy: An overview for neuroscientists","volume":"7","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(00)02149-8","article-title":"Epilepsy in elderly people","volume":"355","author":"Stephen","year":"2000","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kubista, H., Boehm, S., and Hotka, M. (2019). The paroxysmal depolarization shift: Reconsidering its role in epilepsy, epileptogenesis and beyond. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030577"},{"key":"ref_19","unstructured":"Schachter, S.C. (2016). Evaluation of the first seizure in adults. UpToDate, 1\u201325."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1528-1167.2005.31405.x","article-title":"Photic- and pattern-induced seizures: A review for the epilepsy foundation of america working group","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.yebeh.2008.05.004","article-title":"Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review","volume":"13","author":"Pittau","year":"2008","journal-title":"Epilepsy Behavior."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1528-1167.2008.01554.x","article-title":"The diagnostic value of oral lacerations and incontinence during convulsive \u201cseizures\u201d","volume":"49","author":"Oliva","year":"2008","journal-title":"Epilepsia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000285084.93652.43","article-title":"Practice parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"69","author":"Krumholz","year":"2007","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.0b013e318203e9d1","article-title":"Quality improvement in neurology: AAN epilepsy quality measures: Report of the quality measurement and reporting subcommittee of the American Academy of Neurology","volume":"76","author":"Fountain","year":"2011","journal-title":"Neurology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2017.03.001","article-title":"Electroencephalography after a single unprovoked seizure","volume":"49","author":"Debicki","year":"2017","journal-title":"Seizure"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ene.12739","article-title":"The diagnostic accuracy of routine electroencephalography after a first unprovoked seizure","volume":"23","author":"Bouma","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrn2898","article-title":"The dual role of the extracellular matrix in synaptic plasticity and homeostasis","volume":"11","author":"Dityatev","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuron.2008.04.002","article-title":"Astrocytes in the Epileptic Brain","volume":"58","author":"Wetherington","year":"2008","journal-title":"Neuron"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"a022368","DOI":"10.1101\/cshperspect.a022368","article-title":"Initiation, propagation, and termination of partial (Focal) seizures","volume":"5","author":"Avoli","year":"2015","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"ref_30","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"Pharm. Ther."},{"key":"ref_31","unstructured":"Kasper, D., Fauci, A., Hauser, S., Longo, D., and Jameson, J. (2015). Harrison\u2019s Principles of Internal Medicine, 19e, McGraw-Hill."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/2152-7806.91610","article-title":"Vagus nerve stimulation for epilepsy: A review of the peripheral mechanisms","volume":"3","author":"Krahl","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8159.1991.tb04051.x","article-title":"Balance and Cognitive Impairment in Two Epileptic Patients Before and After Vagal Nerve Stimulation","volume":"14","author":"Clarke","year":"1991","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_34","unstructured":"(2021, May 01). Xcorpi FDA, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212839s000lbl.pdf."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1060028020941113","article-title":"Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy","volume":"55","author":"Buckley","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/cpdd.769","article-title":"Pharmacokinetics of Cenobamate: Results from Single and Multiple Oral Ascending-Dose Studies in Healthy Subjects","volume":"9","author":"Vernillet","year":"2020","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Greene, S., Orlinski, L., Streicher, C., and Vernillet, L. (2019). The Pharmacokinetics of Cenobamate in Special Populations (P1.5-034). Neurology, 92.","DOI":"10.1212\/WNL.92.15_supplement.P1.5-034"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2019.05.007","article-title":"Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons","volume":"855","author":"Nakamura","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_39","unstructured":"Jawabri, K.H., and Sharma, S. (2019). Physiology, Cerebral Cortex Functions. StatPearls."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"173117","DOI":"10.1016\/j.ejphar.2020.173117","article-title":"Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate","volume":"879","author":"Sharma","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"P1.5-033","DOI":"10.1212\/WNL.92.15_supplement.P1.5-033","article-title":"Effects of Cenobamate on GABA-A Receptor Modulation (P1.5-033)","volume":"92","author":"Sharma","year":"2019","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"P5.280","DOI":"10.1212\/WNL.90.15_supplement.P5.280","article-title":"Pharmacokinetics of Cenobamate (YKP3089): Results from Single and Multiple Oral Rising-Dose Studies in Healthy Subjects (P5.280)","volume":"90","author":"Vernillet","year":"2018","journal-title":"Neurology"},{"key":"ref_43","first-page":"e559","article-title":"Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)","volume":"93","author":"Diventura","year":"2019","journal-title":"Neurology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1212\/WNL.0000000000009530","article-title":"Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures","volume":"94","author":"Chung","year":"2020","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1474-4422(19)30399-0","article-title":"Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: A multicentre, double-blind, randomised, placebo-controlled, dose-response trial","volume":"19","author":"Krauss","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1535759720903032","article-title":"Remarkably High Efficacy of Cenobamate in Adults with Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Klein, P., Krauss, G.L., Aboumatar, S., and Kamin, M. (2020). Long-Term Efficacy and Safety of Adjunctive Cenobamate in Patients with Uncontrolled focal Seizures: Open-Label Extension of a Randomized Clinical Study. Neurology, 94.","DOI":"10.1212\/WNL.94.15_supplement.1008"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/13\/2\/26\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:17Z","timestamp":1760163137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/13\/2\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["neurolint13020026"],"URL":"https:\/\/doi.org\/10.3390\/neurolint13020026","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}